Monopar Therapeutics Growth Metrics (2017-2020) | MNPR

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020
Growth Ratios
Assets Growth (1y) 242.98%-26.31%-30.55%-33.76%-35.23%82.46%102.07%128.82%255.40%
Assets Growth (3y) 66.45%
Assets (QoQ) -7.89%-7.67%-6.62%-7.22%-13.18%-11.94%-8.69%161.36%-3.84%-0.28%41.81%
Cash & Equivalents Growth (1y) 240.48%152.65%91.96%-28.05%-29.54%-34.46%-37.58%-41.00%91.71%114.12%144.57%300.10%
Cash & Equivalents Growth (3y) 66.30%52.49%43.10%19.31%
Cash & Equivalents (QoQ) 23.62%20.55%147.30%-7.61%-8.27%-8.41%-7.31%-9.52%-14.68%-12.77%-12.38%194.00%-4.70%-0.37%43.33%
Cash from Operations Growth (1y) -159.67%-146.74%49.82%36.37%-23.13%1.74%-2.29%-28.79%-13.01%-34.57%-112.07%
Cash from Operations Growth (3y) -53.45%-48.31%-2.87%
Cash from Operations (QoQ) 2.04%-291.58%31.70%0.88%6.92%20.36%13.40%-91.82%25.73%17.10%-9.04%-68.32%11.56%-30.64%
EBIT Growth (1y) -140.01%-12.20%95.52%-25.73%-56.85%-39.64%-13.77%-32.23%
EBIT (QoQ) -59.15%-2,403.97%95.05%-21.78%25.60%0.00%-38.77%-51.92%33.77%18.52%-61.29%
EBT Growth (1y) -140.01%-12.20%95.52%-25.73%-56.85%-39.64%-13.77%-32.23%
EBT (QoQ) -59.15%-2,403.97%95.05%-21.78%25.60%0.00%-38.77%-51.92%33.77%18.52%-61.29%
Enterprise Value Growth (1y) -240.48%-152.65%-91.96%28.05%29.54%34.46%37.58%41.00%2,417.99%1,179.92%1,401.88%978.51%
Enterprise Value Growth (3y) 286.22%170.91%160.11%78.94%
Enterprise Value (QoQ) -23.62%-20.55%-147.30%7.61%8.27%8.41%7.31%9.52%14.68%12.77%12.38%3,654.85%-60.25%5.15%-40.88%
EPS (Basic) Growth (1y) -125.00%0.00%95.83%-100.00%-66.67%-42.86%-14.29%-30.00%
EPS (Basic) (QoQ) -75.00%-2,300.00%97.02%-80.00%22.22%0.00%-42.86%-50.00%33.33%20.00%-62.50%
Free Cash Flow Growth (1y) -159.67%-146.74%49.82%36.37%-23.13%1.74%-2.29%-28.79%-13.01%-34.57%-112.07%
Free Cash Flow Growth (3y) -53.45%-48.31%-2.87%
Free Cash Flow (QoQ) 2.04%-291.58%31.70%0.88%6.92%20.36%13.40%-91.82%25.73%17.10%-9.04%-68.32%11.56%-30.64%
Net Cash Flow Growth (1y) -219.21%-203.14%-109.51%9.99%-24.85%0.11%-4.50%1,301.71%38.85%93.48%967.33%
Net Cash Flow Growth (3y) -42.77%-27.39%-4.84%
Net Cash Flow (QoQ) 7.57%764.01%-112.78%-0.35%6.92%20.36%-21.00%-39.19%25.53%16.69%1,491.46%-107.08%92.05%11,174.54%
Net Income Growth (1y) -140.01%-12.20%95.52%-25.73%-56.85%-39.64%-13.77%-32.23%
Net Income (QoQ) -59.15%-2,403.97%95.05%-21.78%25.60%0.00%-38.77%-51.92%33.77%18.52%-61.29%
Net Income towards Common Stockholders Growth (1y) -140.01%-12.20%95.52%-25.73%-56.85%-39.64%-13.77%-32.23%
Net Income towards Common Stockholders (QoQ) -59.15%-2,403.97%95.05%-21.78%25.60%0.00%-38.77%-51.92%33.77%18.52%-61.29%
Operating Income Growth (1y) -140.01%-12.20%95.52%-25.73%-56.85%-39.64%-13.77%-32.23%
Operating Income (QoQ) -59.15%-2,403.97%95.05%-21.78%25.60%0.00%-38.77%-51.92%33.77%18.52%-61.29%
Profit After Tax Growth (1y) -135.00%-8.24%95.70%-24.79%-57.04%-41.47%-14.98%-35.53%
Profit After Tax (QoQ) -58.60%-2,415.38%95.20%-22.81%26.95%0.00%-39.09%-54.55%34.19%18.73%-63.96%
Return on Assets Growth (1y) 126.00130.00-39.00-5.00
Return on Assets (QoQ) -16.00159.00-5.00-12.00-12.00-9.0028.00
Return on Capital Employed Growth (1y) 127.00132.00-45.00-7.00
Return on Capital Employed (QoQ) -18.00165.00-6.00-15.00-13.00-11.0032.00
Return on Equity Growth (1y) 128.00130.00-45.00-7.00
Return on Equity (QoQ) -17.00165.00-6.00-14.00-14.00-10.0032.00
Share-based Compensation Growth (1y) -55.29%112.28%268.72%104.12%190.88%160.56%18.80%44.80%42.59%16.78%
Share-based Compensation Growth (3y) 22.86%86.23%
Share-based Compensation (QoQ) -77.83%43.85%81.24%-22.66%5.28%149.87%0.34%10.21%-5.70%13.93%22.29%8.53%-22.77%
Shareholder's Equity Growth (1y) 239.78%-28.08%-34.81%-36.89%-38.95%82.53%114.68%137.08%278.20%
Shareholder's Equity Growth (3y) 64.61%
Shareholder's Equity (QoQ) -7.92%-8.29%-6.74%-8.68%-16.54%-11.21%-9.79%173.04%-1.84%-1.94%43.91%
Total Debt (QoQ) 0.00%